University of Michigan Health System - Ann Arbor /ID# 267275

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab	Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Infections, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, Suppuration, atopic eczema, bacterial infectious disease, dermatitis, hereditary disease, hereditary skin disorder, hidradenitis, hidradenitis suppurativa, immune system disorder, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder	Recruiting	Phase 2	2025-01-24		NCT06524635

Clinical trials